Skip to main content
FinSpry Logo
FinSpry
APRE logo
APRE
(NASDAQ)
Aprea Therapeutics, Inc.
$0.73-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Aprea Therapeutics (APRE) Stock Price & Financial Analysis

Aprea Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.69 - $0.74
52-Week High$2.22
52-Week Low$0.55
Open$0.70
Volume98.14K
Average Volume (3M)175.18K
Market Cap4.77M
Shares Outstanding6.54M
Price to Sales (P/S)16.69
Price to Book (P/B)0.38
EV/EBITDA0.74
Revenue (TTM)285.76K
Net Income (TTM)-12.60M
Free Cash Flow (TTM)-12.89M
EPS (TTM)$-1.93
Profit Margin-4409.16%
Operating Margin-4631.12%
Return on Equity (ROE)-101.27%
Debt to Equity0.00
50-Day MA$0.85
200-Day MA$1.02
52-Week Change-58.80%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Aprea Therapeutics

What is the current stock price for APRE?

As of the latest trading session, APRE stock trades at $0.73. The 52-week range is $0.55–$2.22, with a day range of $0.69–$0.74.

What is the P/E ratio for APRE?

The P/E ratio (Price-to-Earnings) for APRE is shown in the Key Statistics section. This valuation metric helps compare Aprea Therapeutics, Inc. to industry peers.

Does APRE pay dividends?

Aprea Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for APRE?

Based on 2 analysts, the consensus for APRE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of APRE?

Aprea Therapeutics's market capitalization is $4.8M, classifying it as a micro-cap company. Aprea Therapeutics operates in the Healthcare sector within the Biotechnology industry.